H Henry Lai1, Joel Vetter2, Sanjay Jain3, Robert W Gereau4, Gerald L Andriole2. 1. Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. Electronic address: laih@wustl.edu. 2. Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. 3. Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. 4. Department of Anesthesiology and Washington University Pain Center, Washington University School of Medicine, St. Louis, Missouri.
Abstract
PURPOSE: We compared symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder based on patient self-reported symptoms on validated questionnaires. MATERIALS AND METHODS: We prospectively recruited 26 patients diagnosed with interstitial cystitis/bladder pain syndrome, 53 diagnosed with overactive bladder and 30 healthy controls to participate in a questionnaire based study that inquired about lower urinary tract symptoms. The questionnaires used were GUPI, ICSI, ICPI, ICIQ-OAB, ICIQ-UI, IUSS, numerical rating scales of the severity of bladder pain, pressure or discomfort, and numerical rating scale of the severity of urgency and frequency symptoms. RESULTS: On univariate analysis patients with interstitial cystitis/bladder pain syndrome reported significantly more severe pain symptoms than those with overactive bladder. Patients with overactive bladder reported significantly more severe urinary incontinence symptoms than those with interstitial cystitis/bladder pain syndrome. There was no difference in frequency and urgency severity between the groups. Surprisingly, 33% of patients with overactive bladder reported pain or discomfort when the bladder filled and 46% with interstitial cystitis/bladder pain syndrome reported urgency incontinence. On multivariate analysis ICIQ-UI total scores (p = 0.01) and bladder pain severity on the numerical rating scale (p <0.01) distinguished the 2 conditions with 90.6% sensitivity and 96.1% specificity. Overactive bladder had higher ICIQ-UI and lower numerical rating scale pain scores. CONCLUSIONS: There is considerable overlap of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder. This overlap raises the possibility that the 2 conditions represent a continuum of a bladder hypersensitivity syndrome.
PURPOSE: We compared symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder based on patient self-reported symptoms on validated questionnaires. MATERIALS AND METHODS: We prospectively recruited 26 patients diagnosed with interstitial cystitis/bladder pain syndrome, 53 diagnosed with overactive bladder and 30 healthy controls to participate in a questionnaire based study that inquired about lower urinary tract symptoms. The questionnaires used were GUPI, ICSI, ICPI, ICIQ-OAB, ICIQ-UI, IUSS, numerical rating scales of the severity of bladder pain, pressure or discomfort, and numerical rating scale of the severity of urgency and frequency symptoms. RESULTS: On univariate analysis patients with interstitial cystitis/bladder pain syndrome reported significantly more severe pain symptoms than those with overactive bladder. Patients with overactive bladder reported significantly more severe urinary incontinence symptoms than those with interstitial cystitis/bladder pain syndrome. There was no difference in frequency and urgency severity between the groups. Surprisingly, 33% of patients with overactive bladder reported pain or discomfort when the bladder filled and 46% with interstitial cystitis/bladder pain syndrome reported urgency incontinence. On multivariate analysis ICIQ-UI total scores (p = 0.01) and bladder pain severity on the numerical rating scale (p <0.01) distinguished the 2 conditions with 90.6% sensitivity and 96.1% specificity. Overactive bladder had higher ICIQ-UI and lower numerical rating scale pain scores. CONCLUSIONS: There is considerable overlap of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder. This overlap raises the possibility that the 2 conditions represent a continuum of a bladder hypersensitivity syndrome.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein Journal: Am J Obstet Gynecol Date: 2002-07 Impact factor: 8.661
Authors: Kenneth M Peters; Donna J Carrico; Scott E Kalinowski; Ibrahim A Ibrahim; Ananias C Diokno Journal: Urology Date: 2007-07 Impact factor: 2.649
Authors: Joop P van de Merwe; Jørgen Nordling; Pierre Bouchelouche; Kirsten Bouchelouche; Mauro Cervigni; L Kurosch Daha; Suzy Elneil; Magnus Fall; Gero Hohlbrugger; Paul Irwin; Svend Mortensen; Arndt van Ophoven; John L Osborne; Ralph Peeker; Benedikte Richter; Claus Riedl; Jukka Sairanen; Martina Tinzl; Jean-Jacques Wyndaele Journal: Eur Urol Date: 2007-09-20 Impact factor: 20.096
Authors: J Quentin Clemens; Elizabeth A Calhoun; Mark S Litwin; Mary McNaughton-Collins; John W Kusek; Evelyn M Crowley; J Richard Landis Journal: Urology Date: 2009-10-02 Impact factor: 2.649
Authors: D Porru; R Politanò; M Gerardini; G L Giliberto; S Stancati; L Pasini; C Tinelli; B Rovereto Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2004-02-05
Authors: William Stuart Reynolds; Elizabeth Timbrook Brown; Jill Danford; Melissa Kaufman; Alan Wein; Roger Dmochowski; Stephen Bruehl Journal: Neurourol Urodyn Date: 2016-07-19 Impact factor: 2.696
Authors: Eva Raphael; Stephen K Van Den Eeden; Carolyn J Gibson; Chris Tonner; David H Thom; Leslee Subak; Alison J Huang Journal: Am J Obstet Gynecol Date: 2021-09-20 Impact factor: 8.661
Authors: W Stuart Reynolds; Stephen Mock; Xuechao Zhang; Melissa Kaufman; Alan Wein; Stephen Bruehl; Roger Dmochowski Journal: Neurourol Urodyn Date: 2016-07-01 Impact factor: 2.696
Authors: Casey G Kowalik; Joshua A Cohn; Sophia Delpe; Melissa R Kaufman; Alan Wein; Roger R Dmochowski; W Stuart Reynolds Journal: J Urol Date: 2018-07-11 Impact factor: 7.450